Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicity
Cancer, 05/02/2012Qaddoumi I et al.
The combination of topotecan and vincristine is effective for the treatment of advanced intraocular retinoblastoma. Granulocyte colony–stimulating factor treatment alleviates the duration of grade 4 neutropenia. Appropriate topotecan starting doses for patients 0–3,3–6,6–9,9–12, and >12months of age are specified.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.